The most recent Form 13F filing that the company made with the Securities and Exchange Commission revealed that during the ...
Cantor Fitzgerald's research analysts reportedly increased their target price for Cerevel Therapeutics (NASDAQ: CERE) on Tuesday, moving it from $41.00 ...
According to a report made public by The Fly, research analysts at JPMorgan Chase & Co. lowered their price objective ...
Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) gapped lower when trading started on Tuesday after JPMorgan Chase & Co. ...
According to Bloomberg, the ten rating agencies now covering the company have given the stock of Cerevel Therapeutics Holdings, Inc. ...
The parent company of Cerevel Therapeutics Holdings, Inc. is CERE (NASDAQ: CERE). HC Wainwright lowered travel Therapeutics' FY2022 EPS prediction ...
According to data from Bloomberg Ratings, the ten brokerages actively covering Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) have collectively given ...
Research analysts at Bank of America have reportedly started covering shares of Cerevel Therapeutics (NASDAQ: CERE), as The Fly (NASDAQ: ...
Insider John Renger completed a transaction on October 4 involving the sale of 25,000 shares in Cerevel Therapeutics Holdings Inc. ...
The seven research firms currently monitoring Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) have given the stock an average rating of ...
